Skinobs publishes the summary of a ground-breaking market study of clinical tests for the beauty industry
During the first half of 2022, Skinobs carried out an international study on the market for clinical tests for the beauty industry, and has published a summary of the results. The study concerns the development of skin, hair, scalp and nail care products. It covers efficacy, safety and tolerance measurements, consumer testing and sensory analysis. A summary of the study is available online.
Two approaches, one involving clinical test managers at manufacturers and brands, the other involving laboratories, have enabled us to draw up an original and unprecedented panorama of the testing business at the heart of a global beauty market worth 228 billion euros, which is particularly resilient and dynamic in Europe.
In 2021, skin care alone will account for 41% of sales, followed by hair care (22%) and make-up (16%). Perfumes and hygiene products account for 11 and 10% respectively.
The study outlines the trends and concerns of the players involved, indicates the key criteria used by clinical evaluation managers to select laboratories, geographically locates the key centers of test activity, with Europe in the lead, and segments the main players according to their age, size, etc.
A complete study and personalized support: The comprehensive 50-page study, illustrated with graphs, sheds light on the value of this market, both qualitatively and quantitatively. Skinobs offers insight and personalized recommendations for players wishing to deploy a coherent, sustainable development strategy for their products and services.
